NeuroCycle Therapeutics, Inc. is a privately held biopharmaceutical company dedicated to the discovery, development, and commercialization of small-molecule drugs that target the central nervous system. Our goal is to maximize the humanitarian impact and commercial potential of our innovative technologies by targeting both common, highly prevalent disorders with a large unmet medical need, and orphan indications neglected by large pharmaceutical companies. This approach has tremendous potential to bring positive change to our world and impact patients’ lives.

If you are a potential investor, strategic partner, or like-minded individual that wants to help make our vision a reality; please contact us by the contact form or email us at